
Strategic Intelligence: Companion Diagnostics (2025)
Description
Strategic Intelligence: Companion Diagnostics (2025)
Summary
Companion diagnostics (CDx) are medical devices, most commonly an in vitro diagnostic (IVD) that provides information necessary for the safe and effective use of a corresponding drug or biological product. CDx support the expansion of personalized medicine by assessing predictive biomarkers, such as genetic variation or protein expression, in individual patients to determine the most effective use of an associated therapy.
Scope
Summary
Companion diagnostics (CDx) are medical devices, most commonly an in vitro diagnostic (IVD) that provides information necessary for the safe and effective use of a corresponding drug or biological product. CDx support the expansion of personalized medicine by assessing predictive biomarkers, such as genetic variation or protein expression, in individual patients to determine the most effective use of an associated therapy.
Scope
- Oncology is still the most common use for companion diagnostics, as they play a crucial role in the development of targeted therapies
- Companion diagnostics can be used to identify patients who are likely to benefit from a particular therapy
- There is potential for companion diagnostics to be applied in other therapy areas, such as rare diseases, neurological disorders and cardiovascular diseases.
- Understand how companion diagnostics are evolving, the current uses and future potential.
- Understand the key players, the challengers, and product offerings.
- Understand key applications of companion diagnostics.
Table of Contents
43 Pages
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.